User Ratings

Your rating: None
Your rating: None
Your rating: None
Add your comments

Expression and Purification of Thioredoxin Fusion Proteins

John McCoy1,  EdwardLa Ville1

1Genetics Institute, Cambridge, Massachusetts

Unit Number: 
Unit 6.7
DOI: 
10.1002/0471140864.ps0607s10
Online Posting Date: 
May, 2001
GO TO THE FULL TEXT:
PDF or HTML at Wiley Online Library
Are you the author of this protocol? Login or register and return to this page.

Abstract

This unit describes a gene fusion expression system that uses thioredoxin, the product of the Escherichia coli trxA gene, as the fusion partner. The inherent thermal stability of thioredoxin and its susceptibility to quantitative release from the E. coli cytoplasm by osmotic shock can also be exploited as useful tools for thioredoxin fusion protein purification. In this protocol, a fusion of trxA to any desired gene is constructed and the resulting fusion protein is expressed in an appropriate host strain. Additional protocols describe E. coli cell lysis and fractionation, osmotic release of thioredoxin fusion proteins from the E. coli cytoplasm, and heat treatment to purify some thioredoxin fusion proteins.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Unit Introduction
  • Strategic Planning
  • Basic Protocol: Construction and Expression of a Thioredoxin Fusion Protein
  • Support Protocol 1: E. coli Lysis Using a French Pressure Cell
  • Support Protocol 2: Osmotic Release of Thioredoxin Fusion Proteins
  • Support Protocol 3: Purification of Thioredoxin Fusion Proteins by Heat Treatment
  • Reagents and Solutions
  • Commentary
  • Bibliography
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol: Construction and Expression of a Thioredoxin Fusion Protein

 Materials
  • DNA fragment encoding desired sequence
  • Thioredoxin expression vectors (Fig. 6.7.1): pTRXFUS or pALtrxA-781 (Genetics Institute or Invitrogen) or hpTRXFUS (Genetics Institute)
  • E. coli strain GI724 (Genetics Institute or Invitrogen), grown in LB medium and made competent
  • LB medium (unit 5.2)
  • IMC plates (see recipe) containing 100 µg/ml ampicillin
  • CAA/glycerol/ampicillin 100 medium (see recipe)
  • IMC medium (see recipe) containing 100 µg/ml ampicillin
  • 10 mg/ml tryptophan (see recipe)
  • SDS-PAGE sample buffer (see recipe)
  • 30°C convection incubator
  • 18 × 50–mm culture tubes
  • Roller drum (New Brunswick Scientific)
  • 250-ml culture flask
  • 70°C water bath
  • Microcentrifuge, 4°C
  • Additional reagents and equipment for SDS-PAGE (unit 10.1), and Coomassie brilliant blue staining (unit 10.5)

Support Protocol 1: E. coli Lysis Using a French Pressure Cell

 Materials
  • Cell pellet from 4-hr post-induction culture (see Basic Protocol)
  • 20 mM Tris×Cl, pH 8.0 (appendix 2E), 4°C
  • Lysis buffer: 20 mM Tris×Cl (pH 8.0) with protease inhibitors (optional)—0.5 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM p-aminobenzamidine (PABA), and 5 mM EDTA
  • SDS-PAGE sample buffer (see recipe)
  • French press and 3.5-ml mini-cell (SLM Instruments), 4°C
  • Additional reagents and equipment for SDS-PAGE (unit 10.1)

Support Protocol 2: Osmotic Release of Thioredoxin Fusion Proteins

 Materials
  • Cell pellet from 4-hr post-induction cultures (see Basic Protocol)
  • 20 mM Tris×Cl (pH 8.0)/2.5 mM EDTA/20% (w/v) sucrose, ice-cold
  • 20 mM Tris×Cl (pH 8.0)/2.5 mM EDTA, ice-cold
  • Additional reagents and equipment for SDS-PAGE (unit 10.1)

Support Protocol 3: Purification of Thioredoxin Fusion Proteins by Heat Treatment

 Materials
  • Cell pellet from 4-hr post-induction cultures (See Basic Protocol)
  • 20 mM Tris×Cl (pH 8.0)/2.5 mM EDTA
  • SDS-PAGE sample buffer (see recipe)
  • 80°C water bath
  • 10-ml glass-walled tube
  • Additional reagents and equipment for lysis using a French pressure cell (Support Protocol 1) and SDS-PAGE (unit 10.1)
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

  • Figure 6.7.1
    Thioredoxin gene fusion expression vectors pTRXFUS, hpTRXFUS, and pALtrxA-781. pALtrxA-781 contains a polylinker sequence at the 3¢ end of the trxA gene. pTRXFUS and hpTRXFUS contain a linker region encoding a peptide that includes the enterokinase cleavage site between the trxA gene and the polylinker. The sequence surrounding the active site loop of thioredoxin has a single RsrII site that can be used to insert peptide coding sequence. The asterisk indicates a translational stop codon. Abbreviations: trxA, E. coli thioredoxin gene; BLA, -lactamase gene; ori, colE1 replication origin; pL, bacteriophage major leftward promoter; aspA terminator, E. coli aspartate amino-transferase transcription terminator.

  • Figure 6.7.2
    Expression of thioredoxin gene fusions. The gel shows proteins found in the soluble fractions derived from E. coli cells expressing eleven different thioredoxin gene fusions. Lane 1, host E. coli strain GI724 (negative control, 37°C); lane 2, murine interleukin-2 (IL-2; 15°C); lane 3, human IL-3 (15°C); lane 4, murine IL-4 (15°C); lane 5, murine IL-5 (15°C); lane 6, human IL-6 (25°C); lane 7, human MIP-1a (37°C); lane 8, human IL-11 (37°C); lane 9, human macrophage colony-stimulating factor (M-CSF; 37°C); lane 10, murine leukemia inhibitory factor (LIF; 25°C); lane 11, murine steel factor (SF; 37°C); and lane 12, human bone morphogenetic protein-2 (BMP-2; 25°C). Temperatures in parentheses are the production temperature chosen for expressing each fusion. This is a 10% SDS-polyacrylamide gel, stained with Coomassie brilliant blue.

Literature Cited

 Literature Cited
    Bardwell, J.C.A., McGovern, K., and Beckwith, J. 1991. Identification of a protein required for disulfide bond formation in vivo. Cell 67:581-589.
    Edman, J.C., Ellis, L., Blacher, R.W., Roth, R.A., and Rutter, W.J. 1985. Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 317:267-270.
    Hannestad, U., Lundqvist, P., and Sorbo, B. 1982. An agarose derivative containing an arsenical for affinity chromatography of thiol compounds. Anal. Biochem. 126:200-204.
    Hoffman, R.D. and Lane, M.D. 1992. Isodophenylarsine oxide and arsenical affinity chromatography: New probes for dithiol proteins. J. Biol.Chem. 267:14005-14011.
    Holmgren, A. 1985. Thioredoxin. Ann. Rev. Biochem. 54:237-271.
    Katti, S.K., LeMaster, D.M., and Eklund, H. 1990. Crystal structure of thioredoxin from Escherichia coli at 1.68 angstroms resolution. J. Mol. Biol. 212:167-184.
    Kelley, R.F., Shalongo, M., Jagannadham, M.V., and Stellwagen, E. 1987. Equilibrium and kinetic measurements of the conformational transition of reduced thioredoxin. Biochemistry 26:1406-1411.
    LaVallie, E.R., Rehemtulla, A., Racie, L.A., DiBlasio, E.A., Ferenz, C., Grant, K.L., Light, A., and McCoy, J.M. 1993a. Cloning and functional expression of a cDNA encoding the catalytic subunit of bovine enterokinase. J. Biol. Chem. 268:23311-23317.
    LaVallie, E.R., DiBlasio, E.A., Kovacic, S., Grant, K.L., Schendel, P.F., and McCoy, J.M. 1993b. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology 11:187-193.
    Lu, Z., DiBlasio-Smith, E.A., Grant, K.L., Warne, N.W., LaVallie, E.R., Collins-Racie, L.A., Follettie, M.T., Williamson, M.J., and McCoy, J.M. 1996. Histidine patch thioredoxins. Mutant forms of thioredoxin with metal chelating affinity that provide for convenient purifications of thioredoxin fusion proteins. J. Biol. Chem. 271:5059-5065.
    Lunn, C.A. and Pigiet, V.P. 1982. Localization of thioredoxin from Escherichia coli in an osmotically sensitive compartment. J. Biol.Chem. 257:11424-11430.
    Mazzarella, R.A., Srinivasan, M., Haugejorden, S.M., and Green, M. 1990. ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J. Biol. Chem. 265:1094-1101.
    McCoy, J.M. 1992. Heat-shock proteins and their potential uses for pharmaceutical protein production in microorganisms. In Stability of Protein Pharmaceuticals, Part B. (T. Ahern and M. Manning, eds.) pp 287-316. Plenum Press, New York.
    Mieschendahl, M., Petri, T., and Hanggi, U. 1986. A novel prophage independent trp regulated lambda pL expression system. Bio/Technology 4:802-808.
    Mitraki, A. and King, J. 1989. Protein folding intermediates and inclusion body formation. Bio/Technology 7:690-697.
    Norrander, J., Kempe, T., and Messing, J. 1983. Construction of improved M13 vectors using oligonucleotide-directed mutagenesis. Gene 26:101-106.
    Papouchado, M.L., Valdez, S.N., Ghiringhelli, D., Poskus, E., and Ermacora, M.R. 1997. Expression of properly folded human glutamate decarboxylase 65 as a fusion protein in Escherichia coli. Eur. J. Biochem. 246:350-359.
    Riggs, P. 1994. Expression and purification of maltose-binding protein fusions. In Current Protocols in Molecular Biology (F.M. Ausubel, R. Brent, R.F. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds.) pp. 16.6.1-16.6.14. John Wiley & Sons, New York.
    Shatzman, A.R., Gross, M.S., and Rosenberg, M. 1990. Expression using vectors with phage regulatory sequences. In Current Protocols in Molecular Biology (F.M. Ausubel, R. Brent, R.F. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds.) pp. 16.3.1-16.3.11. John Wiley & Sons, New York.
    Shimatake, H. and Rosenberg, M. 1981. Purified regulatory protein cII positively activates promoters for lysogenic development. Nature 292:128-132.
    Shinde, U., Chatterjee, S., and Inouye, M. 1993. Folding pathway mediated by an intramolecular chaperone. Proc. Natl. Acad. Sci. U.S.A. 90:6924-6928.
    Silen, J.L., Frank, D., Fujishige, A., Bone, R., and Agard, D.A. 1989. Analysis of prepro--lytic protease expression in Escherichia coli reveals that the pro region is required for activity. J. Bacteriol. 171:1320-1325.
    Stormo, G.D., Schneider, T.D., and Gold, L. 1982. Characterization of translation initiation sites in E. coli. Nucl. Acids. Res. 10:2971-2996.
 Key Reference
    Ausubel, F.M., Brent, R., Kingston, R.F., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (eds.) 1997. Current Protocols in Molecular Biology. John Wiley & Sons, New York.

A source of protocols for cloning and analyzing DNA.

 Internet Resources
    http://www.invitrogen.com/manuals.html

Source for protocols on affinity-based purification.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library
Looking for Answers?
Do you have tips, tricks, or improvements to share?

Join the Conversation

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.